Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2010, Article ID 635912, 11 pages
http://dx.doi.org/10.1155/2010/635912
Research Article

Activation of PPARs , / , and Impairs TGF- 1-Induced Collagens' Production and Modulates the TIMP-1/MMPs Balance in Three-Dimensional Cultured Chondrocytes

1Laboratoire de Physiologie et Pharmacologie Articulaires (LPPA), UMR 7561 CNRS-UHP Nancy 1, avenue de la Forêt de Haye, BP 184, 54505 Vandœuvre-lès-Nancy Cedex, France
2Laboratoire de Biophotonique et Pharmacologie-UMR CNRS 7213, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 ILLKIRCH Cedex, France

Received 2 May 2010; Revised 13 July 2010; Accepted 30 July 2010

Academic Editor: Beata Lecka-Czernik

Copyright © 2010 Paul-Emile Poleni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. B. Goldring, “The role of the chondrocyte in osteoarthritis,” Arthritis and Rheumatism, vol. 43, no. 9, pp. 1916–1926, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. L. J. Sandell and T. Aigner, “Articular cartilage and changes in arthritis an introduction: cell biology of osteoarthritis,” Arthritis Research, vol. 3, no. 2, pp. 107–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. B. Goldring, “The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models,” Connective Tissue Research, vol. 40, no. 1, pp. 1–11, 1999. View at Google Scholar · View at Scopus
  4. M. B. Sporn and A. B. Roberts, “Transforming growth factor-β. Multiple actions and potential clinical applications,” Journal of the American Medical Association, vol. 262, no. 7, pp. 938–941, 1989. View at Google Scholar · View at Scopus
  5. T. Tsukazaki, T. Usa, T. Matsumoto et al., “Effect of transforming growth factor-β on the insulin-like growth factor-1 autocrine/paracrine axis in cultured rat articular chondrocytes,” Experimental Cell Research, vol. 215, no. 1, pp. 9–16, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Goldberg, D. A. Lee, D. L. Bader, and G. Bentley, “Autologous chondrocyte implantation. Culture in a TGF-β-containing medium enhances the re-expression of a chondrocytic phenotype in passaged human chondrocytes in pellet culture,” Journal of Bone and Joint Surgery. British, vol. 87, no. 1, pp. 128–134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. I. Morales and A. B. Roberts, “Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ cultures,” Journal of Biological Chemistry, vol. 263, no. 26, pp. 12828–12831, 1988. View at Google Scholar · View at Scopus
  8. H. J. Häuselmann, M. B. Aydelotte, B. L. Schumacher, K. E. Kuettner, S. H. Gitelis, and E. J.-M. A. Thonar, “Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads,” Matrix, vol. 12, no. 2, pp. 116–129, 1992. View at Google Scholar · View at Scopus
  9. M. Demoor-Fossard, M. Boittin, F. Redini, and J.-P. Pujol, “Differential effects of interleukin-1 and transforming growth factor β on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers,” Molecular and Cellular Biochemistry, vol. 199, no. 1-2, pp. 69–80, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. P. E. Poleni, A. Bianchi, S. Etienne et al., “Agonists of peroxisome proliferators-activated receptors (PPAR) α, β/δ or γ reduce transforming growth factor (TGF)-β-induced proteoglycans' production in chondrocytes,” Osteoarthritis and Cartilage, vol. 15, no. 5, pp. 493–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Günther, H.-D. Haubeck, E. Van De Leur et al., “Transforming growth factor β1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes,” Arthritis and Rheumatism, vol. 37, no. 3, pp. 395–405, 1994. View at Google Scholar · View at Scopus
  12. S. Su, J. A. DiBattista, Y. Sun, W. Q. Li, and M. Zafarullah, “Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-β in articular chondrocytes is mediated by serine/threonine and tyrosine kinases,” Journal of Cellular Biochemistry, vol. 70, no. 4, pp. 517–527, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Google Scholar · View at Scopus
  14. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Bishop-Bailey, “Peroxisome proliferator-activated receptors in the cardiovascular system,” British Journal of Pharmacology, vol. 129, no. 5, pp. 823–833, 2000. View at Google Scholar · View at Scopus
  16. T. M. Willson, P. J. Brown, D. D. Sternbach, and B. R. Henke, “The PPARs: from orphan receptors to drug discovery,” Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 527–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. Semple, V. K. K. Chatterjee, and S. O'Rahilly, “PPARγ and human metabolic disease,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 581–589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Kostadinova, W. Wahli, and L. Michalik, “PPARs in diseases: control mechanisms of inflammation,” Current Medicinal Chemistry, vol. 12, no. 25, pp. 2995–3009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Michalik and W. Wahli, “Involvement of PPAR nuclear receptors in tissue injury and wound repair,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 598–606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Fahmi, J.-P. Pelletier, and J. Martel-Pelletier, “PPARγ ligands as modulators of inflammatory and catabolic responses in arthritis. An overview,” Journal of Rheumatology, vol. 29, no. 1, pp. 3–14, 2002. View at Google Scholar · View at Scopus
  21. T. Shiojiri, K. Wada, A. Nakajima et al., “PPARγ ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice,” European Journal of Pharmacology, vol. 448, no. 2-3, pp. 231–238, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kobayashi, K. Notoya, T. Naito et al., “Pioglitazone, a peroxisome proliferator-activated receptor γ agonist, reduces the progression of experimental osteoarthritis in guinea pigs,” Arthritis and Rheumatism, vol. 52, no. 2, pp. 479–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. E. Routh, J. H. Johnson, and K. J. McCarthy, “Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro,” Kidney International, vol. 61, no. 4, pp. 1365–1376, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Miyahara, L. Schrum, R. Rippe et al., “Peroxisome proliferator-activated receptors and hepatic stellate cell activation,” Journal of Biological Chemistry, vol. 275, no. 46, pp. 35715–35722, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Zafiriou, S. R. Stanners, S. Saad, T. S. Polhill, P. Poronnik, and C. A. Pollock, “Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 638–645, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. T. Ballock, A. Heydemann, T. Izumi, and A. H. Reddi, “Regulation of the expression of the type-II collagen gene in periosteum-derived cells by three members of the transforming growth factor-β superfamily,” Journal of Orthopaedic Research, vol. 15, no. 3, pp. 463–467, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Galli, D. W. Crabb, E. Ceni et al., “Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro,” Gastroenterology, vol. 122, no. 7, pp. 1924–1940, 2002. View at Google Scholar · View at Scopus
  28. F. Zheng, A. Fornoni, S. J. Elliot et al., “Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation,” American Journal of Physiology, vol. 282, no. 4, pp. F639–F648, 2002. View at Google Scholar · View at Scopus
  29. A. K. Ghosh, S. Bhattacharyya, G. Lakos, S.-J. Chen, Y. Mori, and J. Varga, “Disruption of transforming growth factor β signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor γ,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1305–1318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. H. A. Burgess, L. E. Daugherty, T. H. Thatcher et al., “PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis,” American Journal of Physiology, vol. 288, no. 6, pp. L1146–L1153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. W. Park, H. W. Kim, S. H. Ko et al., “Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor a,” Diabetes, vol. 55, no. 4, pp. 885–893, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Seimandi, G. Lemaire, A. Pillon et al., “Differential responses of PPARα, PPARδ, and PPARγ reporter cell lines to selective PPAR synthetic ligands,” Analytical Biochemistry, vol. 344, no. 1, pp. 8–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. S. Tan, L. Michalik, N. Di-Poï et al., “Essential role of Smad3 in the inhibition of inflammation-induced PPARβ/δ expression,” The EMBO Journal, vol. 23, no. 21, pp. 4211–4221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. W.-N. Qi and S. P. Scully, “Extracellular collagen regulates expression of transforming growth factor-β1 gene,” Journal of Orthopaedic Research, vol. 18, no. 6, pp. 928–932, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Zafarullah, J.-P. Pelletier, J.-M. Cloutier, and J. Martel-Pelletier, “Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia,” Journal of Rheumatology, vol. 20, no. 4, pp. 693–697, 1993. View at Google Scholar · View at Scopus
  36. S. Su, J. Grover, P. J. Roughley et al., “Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints,” Rheumatology International, vol. 18, no. 5-6, pp. 183–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Leco, R. Khokha, N. Pavloff, S. P. Hawkes, and D. R. Edwards, “Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues,” Journal of Biological Chemistry, vol. 269, no. 12, pp. 9352–9360, 1994. View at Google Scholar · View at Scopus
  38. S. Su, F. Dehnade, and M. Zafarullah, “Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-β and dexamethasone in bovine and human articular chondrocytes,” DNA and Cell Biology, vol. 15, no. 12, pp. 1039–1048, 1996. View at Google Scholar · View at Scopus
  39. L. Wang, K. F. Almqvist, E. M. Veys, and G. Verbruggen, “Control of extracellular matrix homeostasis of normal cartilage by a TGFβ autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro,” Osteoarthritis and Cartilage, vol. 10, no. 3, pp. 188–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. C. E. Brinckerhoff, “Joint destruction in arthritis: metalloproteinases in the spotlight,” Arthritis and Rheumatism, vol. 34, no. 9, pp. 1073–1075, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. G. C. Wolfe, K. L. MacNaul, F. F. Buechel et al., “Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis,” Arthritis and Rheumatism, vol. 36, no. 11, pp. 1540–1547, 1993. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Koufany, D. Moulin, A. Bianchi et al., “Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis,” Arthritis Research and Therapy, vol. 10, no. 1, article R6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Afif, M. Benderdour, L. Mfuna-Endam et al., “Peroxisome proliferator-activated receptor γ1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1β in articular chondrocytes,” Arthritis Research and Therapy, vol. 9, article R31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Boileau, J. Martel-Pelletier, H. Fahmi, F. Mineau, M. Boily, and J.-P. Pelletier, “The peroxisome proliferator-activated receptor γ agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways,” Arthritis and Rheumatism, vol. 56, no. 7, pp. 2288–2298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Cheng, H. Afif, J. Martel-Pelletier et al., “Association of polymorphisms in the peroxisome proliferator-activated receptor γ gene and osteoarthritis of the knee,” Annals of the Rheumatic Diseases, vol. 65, no. 10, pp. 1394–1397, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Jouzeau, D. Moulin, M. Koufany, S. Sebillaud, A. Bianchi, and P. Netter, “Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases—the pro and con of agonists,” Journal de la Société de Biologie, vol. 202, no. 4, pp. 289–312, 2008. View at Google Scholar · View at Scopus